Synapse - Paul Hamlin

Paul Hamlin

Hamlin paul

Groups

Hematologic Oncology, Division of
- Lymphoma Service
Center for Hematologic Malignancies
- Lymphoma

Research Focus

Medicine; Associate Attending

Recent additions – View all

The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL)
Meeting Abstract

Hamlin, P. A.; Cheson, B. D.; Farber, C. M.; Feldman, T.; Fenske, T. S.; Hess, B. T.; Khatcheressian, J. L.; Miller, C. B.; Munoz, J.; Patel, M. R.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save
Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
Meeting Abstract

Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save
Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
Journal Article

Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications

Blood (64)
Journal of Clinical Oncology (25)
Annals of Oncology (12)
British Journal of Haematology (9)
Hematological Oncology (6)
Biology of Blood and Marrow Transplantation (5)
Clinical Lymphoma, Myeloma and Leukemia (5)
Haematologica (4)
Clinical Cancer Research (3)
Current Oncology Reports (3)